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Introduction
We report a unique case in a 17 year old male patient of
Algerian origin with two rare genetic conditions with over-
lapping clinical symptoms. Familial Mediterranean fever
(FMF) is an autosomal recessive disorder characterized by
sporadic, paroxysmal attacks of fever and serositis. Heredi-
tary coproporphyria (HCP) is one of the type of acute
hepatic porphyria resulting in neurovisceral symptoms
caused by deficient activity of mitochondrial enzyme
coproporphyrinogen oxidase. Both are considered rare
differential diagnosis for acute abdominal pain.
Case report
17 year old boy of Algerian origin presented with long his-
tory of recurrent episodes of fever, abdominal pain since
infancy. He experiencied 3-4 attacks per year each lasting
typically for 2-3 days. There was no family history.
Patient was referred simultaneously to immunology and
metabolic medicine for further assessment. Differential
diagnoses considered at the time included: periodic fever
syndromes, hereditary angioedema, vasculitis and
porphyria.
FBC results over the year showed intermittent leucocy-
tosis during acute attacks with elevated C-reactive protein
(CRP) and plasma viscosity (PV). Serum amyloid A (SAA)
was not measured. Investigations during quiescent phase
showed normal levels of SAA but slightly elevated CRP
13.4 mg/l (ref <10) and neutrophilia of 9.9 x109/l (ref 2.00-
7.50).
Genetic investigations for periodic fever syndromes con-
firmed two pathogenic MEFV gene mutation on sequen-
cing Exon 2 and 10 at p. (Met694IIe(;)Glu148Gln),
supporting diagnoses of FMF. Sequencing for MVK and
TNFRSF1A gene were negative.
Investigations undertaken by metabolic medicine spe-
cialists revealed urine coproporphyrin III at 42.75nmol/
mmol cret (1.2-24.8) with porphrin/creat Ratio of 54.6
nmol/mmol (Ref <28). Faecal porphrin were 1639nmol/
g dry weight (ref <130) with faecal coproporphyrin III: I
ratio at 19.51 (Ref <2). The results confirmed diagnosis
of HCP. Genetic tests are awaited for the patient. He
has management plan for hereditary coproporphyria.
Patient was commenced on colchicine at the dose of
500 micrograms twice daily. No further episodes of
abdominal pain have been reported in the last 9 months
since prophylaxis starting prophylaxis with colchicine.
Discussion
FMF and HCP are both recognised as rare causes of unex-
plained acute abdominal pain associated with fever.
However there are several additional features which would
favour FMF over HCP. The patient’s ethic origin is more
suggestive of FMF. The majority of HPC was reported in
the North European ancestry. The onset of HCP also
tends to be in puberty whilst FMF usually presents in
childhood with initial attacks before the age of 10 in 65%
of cases. Low grade persistent inflammatory response is a
feature of FMF and not necessarily seen HCP. Finally
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